303 related articles for article (PubMed ID: 10666331)
1. Detection of apoptosis induced by topoisomerase inhibitors and serum deprivation in syrian hamster embryo cells.
Alexandre S; Rast C; Nguyen-Ba G; Vasseur P
Exp Cell Res; 2000 Feb; 255(1):30-9. PubMed ID: 10666331
[TBL] [Abstract][Full Text] [Related]
2. Induction of apoptosis in human retinoblastoma cells by topoisomerase inhibitors.
Giuliano M; Lauricella M; Vassallo E; Carabillò M; Vento R; Tesoriere G
Invest Ophthalmol Vis Sci; 1998 Jul; 39(8):1300-11. PubMed ID: 9660477
[TBL] [Abstract][Full Text] [Related]
3. DNA fragmentation induced by protease activation in p53-null human leukemia HL60 cells undergoing apoptosis following treatment with the topoisomerase I inhibitor camptothecin: cell-free system studies.
Shimizu T; Pommier Y
Exp Cell Res; 1996 Aug; 226(2):292-301. PubMed ID: 8806433
[TBL] [Abstract][Full Text] [Related]
4. The topoisomerase inhibitors camptothecin and etoposide induce a CD95-independent apoptosis of activated peripheral lymphocytes.
Ferraro C; Quemeneur L; Fournel S; Prigent AF; Revillard JP; Bonnefoy-Berard N
Cell Death Differ; 2000 Feb; 7(2):197-206. PubMed ID: 10713734
[TBL] [Abstract][Full Text] [Related]
5. Topoisomerase inhibitor camptothecin sensitizes mouse hepatocytes in vitro and in vivo to TNF-mediated apoptosis.
Hentze H; Latta M; Künstle G; Dhakshinamoorthy S; Ng PY; Porter AG; Wendel A
Hepatology; 2004 May; 39(5):1311-20. PubMed ID: 15122760
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of the poly (ADP-ribose) polymerase (PARP) inhibitor NU1025 on topoisomerase I and II inhibitor cytotoxicity in L1210 cells in vitro.
Bowman KJ; Newell DR; Calvert AH; Curtin NJ
Br J Cancer; 2001 Jan; 84(1):106-12. PubMed ID: 11139322
[TBL] [Abstract][Full Text] [Related]
7. Involvement of transcriptional repressor ATF3 in acceleration of caspase protease activation during DNA damaging agent-induced apoptosis.
Mashima T; Udagawa S; Tsuruo T
J Cell Physiol; 2001 Sep; 188(3):352-8. PubMed ID: 11473362
[TBL] [Abstract][Full Text] [Related]
8. Complex response of breast epithelial cell lines to topoisomerase inhibitors.
Davis PL; Shaiu WL; Scott GL; Iglehart JD; Hsieh TS; Marks JR
Anticancer Res; 1998; 18(4C):2919-32. PubMed ID: 9713486
[TBL] [Abstract][Full Text] [Related]
9. c-Myc-dependent etoposide-induced apoptosis involves activation of Bax and caspases, and PKCdelta signaling.
Albihn A; Lovén J; Ohlsson J; Osorio LM; Henriksson M
J Cell Biochem; 2006 Aug; 98(6):1597-614. PubMed ID: 16572399
[TBL] [Abstract][Full Text] [Related]
10. Developmental activation of the capability to undergo checkpoint-induced apoptosis in the early zebrafish embryo.
Ikegami R; Hunter P; Yager TD
Dev Biol; 1999 May; 209(2):409-33. PubMed ID: 10328930
[TBL] [Abstract][Full Text] [Related]
11. Differential cytotoxic pathways of topoisomerase I and II anticancer agents after overexpression of the E2F-1/DP-1 transcription factor complex.
Hofland K; Petersen BO; Falck J; Helin K; Jensen PB; Sehested M
Clin Cancer Res; 2000 Apr; 6(4):1488-97. PubMed ID: 10778981
[TBL] [Abstract][Full Text] [Related]
12. Differential apoptosis-inducing effect of quercetin and its glycosides in human promyeloleukemic HL-60 cells by alternative activation of the caspase 3 cascade.
Shen SC; Chen YC; Hsu FL; Lee WR
J Cell Biochem; 2003 Aug; 89(5):1044-55. PubMed ID: 12874837
[TBL] [Abstract][Full Text] [Related]
13. The cellular prion protein (PrPC) prevents apoptotic neuronal cell death and mitochondrial dysfunction induced by serum deprivation.
Kim BH; Lee HG; Choi JK; Kim JI; Choi EK; Carp RI; Kim YS
Brain Res Mol Brain Res; 2004 Apr; 124(1):40-50. PubMed ID: 15093684
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of apoptosis induced by doxorubicin through the generation of hydrogen peroxide.
Mizutani H; Tada-Oikawa S; Hiraku Y; Kojima M; Kawanishi S
Life Sci; 2005 Feb; 76(13):1439-53. PubMed ID: 15680309
[TBL] [Abstract][Full Text] [Related]
15. Changes in expression of bcl-2 and bax in Syrian hamster embryo (SHE) cells exposed to ZnCl2.
Maire MA; Rast C; Pagnout C; Vasseur P
Arch Toxicol; 2005 Feb; 79(2):90-101. PubMed ID: 15551063
[TBL] [Abstract][Full Text] [Related]
16. E2F activity is essential for survival of Myc-overexpressing human cancer cells.
Santoni-Rugiu E; Duro D; Farkas T; Mathiasen IS; Jäättelä M; Bartek J; Lukas J
Oncogene; 2002 Sep; 21(42):6498-509. PubMed ID: 12226753
[TBL] [Abstract][Full Text] [Related]
17. Ordering of ceramide formation, caspase activation, and Bax/Bcl-2 expression during etoposide-induced apoptosis in C6 glioma cells.
Sawada M; Nakashima S; Banno Y; Yamakawa H; Hayashi K; Takenaka K; Nishimura Y; Sakai N; Nozawa Y
Cell Death Differ; 2000 Sep; 7(9):761-72. PubMed ID: 11042671
[TBL] [Abstract][Full Text] [Related]
18. Synthetic 1,4-anthracenedione analogs induce cytochrome c release, caspase-9, -3, and -8 activities, poly(ADP-ribose) polymerase-1 cleavage and internucleosomal DNA fragmentation in HL-60 cells by a mechanism which involves caspase-2 activation but not Fas signaling.
Perchellet EM; Wang Y; Weber RL; Sperfslage BJ; Lou K; Crossland J; Hua DH; Perchellet JP
Biochem Pharmacol; 2004 Feb; 67(3):523-37. PubMed ID: 15037204
[TBL] [Abstract][Full Text] [Related]
19. The altered apoptotic pathways in cisplatin and etoposide-resistant melanoma cells are drug specific.
Kissel CK; Schadendorf D; Röckmann H
Melanoma Res; 2006 Dec; 16(6):527-35. PubMed ID: 17119454
[TBL] [Abstract][Full Text] [Related]
20. Poly ADP-ribose polymerase (PARP) inhibitors transiently protect leukemia cells from alkylating agent induced cell death by three different effects.
Pogrebniak A; Schemainda I; Pelka-Fleischer R; Nüssler V; Hasmann M
Eur J Med Res; 2003 Oct; 8(10):438-50. PubMed ID: 14594650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
